Description
Seeking adults with Acute Myeloid Leukemia with an NPM1 mutation or KMT2A rearrangement for a study of an investigational drug to be used in combination with other chemotherapy drugs.
Overview
Newly diagnosed participants will get one of three different doses of the investigational drug. The drug will be given in 28-day cycles in combination with chemotherapy.
What we're hoping for
We are studying the safe dose of an investigational new drug to be used in combination with other chemotherapy drugs
Additional Information
ClinicalTrials.gov Identifier: NCT05735184